China South City Holdings $175 million high-yield notes offering
We advised the initial purchasers on the offering
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
I-Mab $177 million follow-on secondary offering of ADSs
We advised the underwriters on the equity offering
JOINN Laboratories HK$6.5 billion IPO
We advised JOINN Laboratories on its IPO and HKEX listing.
Fantasia $150 million high-yield notes reopening and concurrent tender offer
We advised the initial purchasers on the offering and the dealer managers on the tender offer for Fantasia’s senior notes
InnoCare Pharma HK$3.04 billion share placement
We advised InnoCare Pharma in the placement of new shares
New Horizon Health HK$2.04 billion IPO
We advised New Horizon Health on its IPO and HKEX listing
Akeso HK$1.19 billion share placement
We advised the placing agent in the placement of new shares
UP Fintech $65 million convertible notes private placement
We are advising UP Fintech, a Nasdaq-listed online brokerage firm, on its private placement of convertible notes
Youdao $238 million equity follow-on offering
We advised Youdao on its offering of ADSs
Adagene $161 million IPO
We advised Adagene on its IPO and Nasdaq listing